共 15 条
- [1] A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Gunthert U,,Hofmann M,Rudy W,et al. Cell . 1991
- [2] Expression and prognostic value of the CD44splicing variants V5and V6in gastric cancer. Wolfram M,Anke S,Karl H,et al. Journal of Paleopathology . 1997
- [3] Differential expression ofthe human metastasis adhesion molecule CD44v in normal andcarcinomatous stomach mucosa of Chinese subjects. Harn HJ,Ho LI,Chang JY,et al. Cancer . 1995
- [4] Expression of the cell adhesion molecule CD44in gastric adenocarcinomas. Washington K,Gottfried MR,Telen MJ. Human Pathology . 1994
- [5] Expression of CD44alternatives-plicing variants in lung cancer. Dhgami A,Sugio K,Mitsudomi T,et al. Japanese Journal of Clinical Medicine . 1995
- [6] CD44 splice variants as prognosic factors in invasive cervix carcinoma. Reinthaller A,Kainz C,Kohlberger P,et al. Gynakologisch Geburtshilfliche Rundschau . 1995
- [7] Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma. World Journal of Gastroenterology . 2005
- [8] Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma[J]. Zhen-Dong Gu, Ke-Neng Chen, Department of Thoracic Surgery, Peking University School of Oncology, Beijing Cancer Hospital, Beijing 100036, China Ming Li, Jin Gu, Department of General Surgery, Peking University School of Oncology, Beijing Cancer Hospital, Beijing 100036, China Ji-You Li, Department of Pathology, Peking University School of Oncology, Beijing Cancer Hospital, Beijing 100036, Ch
- [10] Clinical significance of matrix metalloproteinase-7 expression in esophogeal carcinoma. Yamashita K,Mori M,Shiraishi T,et al. Clinical Cancer Research . 2000